Mevion withdraws IPO plans; NuVasive settles with DOJ for $13.5M;

@FierceMedDev: FierceDiagnostics story: Foundation Medicine trips in Q2 with sluggish test reimbursement. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: NeuWave Medical gets FDA clearance for software upgrade to its ablation system. Report | Follow @VarunSaxena2

@EmilyWFierce: It's not a good week to be a drugmaker in Romania. More from FiercePharma | Follow @EmilyWFierce

> Proton radiation therapy system maker Mevion Medical Systems has withdrawn plans for an IPO. Its investors include Caxton Associates, ProQuest Investments, Venrock Healthcare Partners and CHL Medical Partners. More

> NuVasive ($NUVA) has settled with the U.S. Department of Justice over allegations of off-label promotions for $13.5 million. More

> GE Healthcare ($GE) and Ochsner Health System have partnered to back a competition to solicit ideas for novel wearable devices and mobile apps to address chronic disease patients. The Phase 1 winners get $1,000 and can move on to Phase 2 where up to 3 winners will get a total of $15,000 for development. The deadline is Sept. 15. More

> Sorin has launched its Reply CRT-P cardiac resynchronization pacemaker, which it says is the world's smallest. More

Biotech News

@FierceBiotech: ICYMI yesterday: Failed Alzheimer's drug wins $117M in vTv's IPO. Article | Follow @FierceBiotech

@JohnCFierce: 125 ex-$GSK R&D staffers in RTP face the ax--again (Great industry. Where else can you get fired twice in 8 months?) News | Follow @JohnCFierce

> Amgen lops another 10% off its R&D budget amid wide cost cuts. Story

> Merck's Ebola vaccine is 100% successful in interim Phase III results. News

> AstraZeneca isn't giving up on brodalumab despite its links to suicide. Article

Pharma News

@FiercePharma: IDEXX shares climb on record diagnostics placements and Q2 earnings gain. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: As Hospira expands recall of ketorolac to 37M vials you've got to wonder what Pfizer thinks. Story | Follow @EricPFierce

@CarlyHFierce: Celgene fights for sanction on patent challenger Bass. More | Follow @CarlyHFierce

> GSK hiring 130 at inhaler facility, even as CRO axes up to 200 GSK alum. Report

> Romania launches bribery probe into 11 drugmakers. Article